XML 20 R7.htm IDEA: XBRL DOCUMENT v3.22.0.1
Consolidated Statements of Changes in Stockholders’ Equity - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Accumulated Other Comprehensive Loss
Beginning balance (in shares) at Dec. 31, 2018   38,466      
Beginning balance at Dec. 31, 2018 $ 71,002 $ 385 $ 239,865 $ (168,140) $ (1,108)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (loss) 31,667     31,667  
Other comprehensive income(loss) 148       148
Stock option exercises and employee stock plan purchases (in shares)   95      
Stock option exercises and employee stock plan purchases 1,746 $ 1 1,745    
Vesting of restricted stock awards and units (in shares)   796      
Vesting of restricted stock awards 0 $ 8 (8)    
Shares withheld to cover taxes (in shares)   (106)      
Shares withheld to cover taxes (2,454) $ (1) (2,453)    
Stock-based compensation 12,492   12,492    
Ending balance (in shares) at Dec. 31, 2019   39,251      
Ending balance at Dec. 31, 2019 114,601 $ 393 251,641 (136,473) (960)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (loss) (13,473)     (13,473)  
Other comprehensive income(loss) (1,088)       (1,088)
Stock option exercises and employee stock plan purchases (in shares)   73      
Stock option exercises and employee stock plan purchases 760 $ 1 759    
Vesting of restricted stock awards and units (in shares)   847      
Vesting of restricted stock awards 0 $ 8 (8)    
Shares withheld to cover taxes (in shares)   (141)      
Shares withheld to cover taxes (2,129) $ (2) (2,127)    
Issuance of common stock (in shares)   26,845      
Issuance of common stock, net of $3,776 issuance costs 394,334 $ 269 394,065    
Fair value of replacement stock options related to precombination services 7,125   7,125    
Stock-based compensation 14,075   14,075    
Ending balance (in shares) at Dec. 31, 2020   66,875      
Ending balance at Dec. 31, 2020 514,205 $ 669 665,530 (149,946) (2,048)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (loss) (71,279)     (71,279)  
Other comprehensive income(loss) 1,563       1,563
Stock option exercises and employee stock plan purchases (in shares)   360      
Stock option exercises and employee stock plan purchases 6,062 $ 3 6,059    
Vesting of restricted stock awards and units (in shares)   611      
Vesting of restricted stock awards 0 $ 6 (6)    
Shares withheld to cover taxes (in shares)   (107)      
Shares withheld to cover taxes (2,046) $ (1) (2,045)    
Stock-based compensation 15,934   15,934    
Ending balance (in shares) at Dec. 31, 2021   67,739      
Ending balance at Dec. 31, 2021 $ 464,439 $ 677 $ 685,472 $ (221,225) $ (485)